Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
1698791 Ontario Ltd. is a private Canadian holding company and investment vehicle owned by William (Bill) Connor. The company is a major shareholder and strategic partner of Biosenta Inc. (CSE: ZRO), a biotechnology firm that develops advanced chemical compounds using encapsulated nanotechnology. Biosenta's products, such as Tri-Filler and Zeromold, are designed to provide high-efficacy, low-toxicity antimicrobial protection for industrial and household applications. 1698791 Ontario Ltd. plays a critical role in Biosenta's corporate structure, frequently participating in debt settlements and joint ventures to support the commercialization of its nanotechnology platform. The company's involvement is central to the financial and strategic development of Biosenta's antimicrobial technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 1698791 Ontario.